False susceptibility to amikacin by VITEK 2 in Acinetobacter baumannii harboring armA.
Amikacin (AN) is the most active aminoglycoside for the treatment of infections caused by Acinetobacter baumannii. The VITEK 2 automated system showed false susceptibility to AN for the A. baumannii isolate harboring armA. This phenomenon was not observed in the Serratia marcescens isolate harboring armA, but was detected in its transconjugant E. coli J53.
Jung
Sunkyung
S
Laboratory Medicine Department, St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Yu
Jin Kyung
JK
Shin
Sang Hyun
SH
Park
Kang Gyun
KG
Jekarl
Dong Wook
DW
Han
Kyungja
K
Park
Yeon-Joon
YJ
D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification; D000583:Amikacin / Q000494:pharmacology*; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D052978:Disk Diffusion Antimicrobial Tests; D024881:Drug Resistance, Bacterial / Q000187:drug effects*; D016521:Electrophoresis, Gel, Pulsed-Field; D005798:Genes, Bacterial / Q000235:genetics*; D008826:Microbial Sensitivity Tests / Q000379:methods*
D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D000583:Amikacin